Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?
- PMID: 17522507
- PMCID: PMC1876968
- DOI: 10.1097/SLA.0b013e31805d0788
Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?
Comment in
-
Re: Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?Ann Surg. 2008 May;247(5):900; author reply 900-1. doi: 10.1097/SLA.0b013e31816ff75c. Ann Surg. 2008. PMID: 18438131 No abstract available.
Comment on
-
A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma.Ann Surg. 2007 Jun;245(6):831-42. doi: 10.1097/01.sla.0000245829.00977.45. Ann Surg. 2007. PMID: 17522506 Free PMC article. Clinical Trial.
References
-
- Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–156. - PubMed
-
- Clavien PA, Petrowsky H, De Oliveira ML, et al. Strategies for safer liver surgery and transplantation of partial liver grafts. N Engl J Med. 2007;356:1545–1559. - PubMed
-
- Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917. - PubMed
-
- Colombo M, Donato MF. Prevention of hepatocellular carcinoma. Semin Liver Dis. 2005;25:155–161. - PubMed
-
- McCormack L, Petrowsky H, Clavien PA. Surgical therapy of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2005;17:497–503. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
